FR2603284A1 - Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique - Google Patents

Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique

Info

Publication number
FR2603284A1
FR2603284A1 FR8711892A FR8711892A FR2603284A1 FR 2603284 A1 FR2603284 A1 FR 2603284A1 FR 8711892 A FR8711892 A FR 8711892A FR 8711892 A FR8711892 A FR 8711892A FR 2603284 A1 FR2603284 A1 FR 2603284A1
Authority
FR
France
Prior art keywords
hydroxamic
heptane
acid derivatives
therapeutic action
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8711892A
Other languages
English (en)
Other versions
FR2603284B1 (fr
Inventor
Eric Michael
Gordon Ravi
Kannadikovilakom Varma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2603284A1 publication Critical patent/FR2603284A1/fr
Application granted granted Critical
Publication of FR2603284B1 publication Critical patent/FR2603284B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

COMPOSES DE FORMULE : (CF DESSIN DANS BOPI) DANS LAQUELLE R EST UN ATOME D'HYDROGENE OU UN RADICAL ALKYLE INFERIEUR, ARYLE, ARALKYLE OU ALCENYLE; R EST UN ATOME D'HYDROGENE OU UN RADICAL ALKYLE INFERIEUR, ALCANOYLE OU AROYLE; R EST UN RADICAL ALKYLE INFERIEUR, ALCENYLE OU ALCYNYLE; A EST -CH-CHCH- OU UNE LIAISON SIMPLE; ET N EST UN NOMBRE ENTIER DE 0 A 9; Y COMPRIS TOUS LES STEREOISOMERES ET SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CES COMPOSES. CES COMPOSES INHIBENT SIMULTANEMENT LA CYCLO-OXYGENASE ET LA 5-LIPOXYGENASE DE L'ACIDE ARACHIDONIQUE ET SONT DONC UTILISABLES COMME AGENTS ANTI-INFLAMMATOIRES, ANTI-ASTHMATIQUES ET ANTIPSORIASIS.
FR878711892A 1986-08-26 1987-08-25 Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique Expired - Fee Related FR2603284B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/900,565 US4672075A (en) 1986-08-26 1986-08-26 7-Oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as antiinflammatory, antiasthma and antipsoriatic agents

Publications (2)

Publication Number Publication Date
FR2603284A1 true FR2603284A1 (fr) 1988-03-04
FR2603284B1 FR2603284B1 (fr) 1990-11-16

Family

ID=25412729

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878711892A Expired - Fee Related FR2603284B1 (fr) 1986-08-26 1987-08-25 Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique

Country Status (7)

Country Link
US (1) US4672075A (fr)
JP (1) JPS6360988A (fr)
CA (1) CA1301179C (fr)
DE (1) DE3728350A1 (fr)
FR (1) FR2603284B1 (fr)
GB (1) GB2194531B (fr)
IT (1) IT1228934B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672075A (en) * 1986-08-26 1987-06-09 E. R. Squibb & Sons 7-Oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as antiinflammatory, antiasthma and antipsoriatic agents
US4707494A (en) * 1986-08-26 1987-11-17 E. R. Squibb & Sons, Inc. 7-oxabicyclo(2.2.1)heptane compounds useful in the treatment of inflammation
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
US5075330A (en) * 1989-05-26 1991-12-24 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents
US5112846A (en) * 1989-05-26 1992-05-12 Warner-Lambert Company N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
EP2424521A4 (fr) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd Compositions pharmaceutiques comprenant de l'epa et un agent cardiovasculaire et leurs procédés d'utilisation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0183238A2 (fr) * 1984-11-30 1986-06-04 E.R. Squibb & Sons, Inc. Analogues de prostaglandine 7-oxabicycloheptane substitué
US4672075A (en) * 1986-08-26 1987-06-09 E. R. Squibb & Sons 7-Oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as antiinflammatory, antiasthma and antipsoriatic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
JPS58113152A (ja) * 1981-12-28 1983-07-05 Ono Pharmaceut Co Ltd ２−アミノフエノ−ル誘導体、その製造方法およびそれらを有効成分として含有する治療剤
US4497827A (en) * 1982-08-30 1985-02-05 Syntex (U.S.A.) Inc. Arachidonic acid analogues as anti-inflammatory and anti-allergic agents
US4582854A (en) * 1983-03-14 1986-04-15 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted oxa prostaglandin analgos useful in the treatment of thrombolytic disease
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0183238A2 (fr) * 1984-11-30 1986-06-04 E.R. Squibb & Sons, Inc. Analogues de prostaglandine 7-oxabicycloheptane substitué
US4672075A (en) * 1986-08-26 1987-06-09 E. R. Squibb & Sons 7-Oxabicyclo(2.2.1)heptane hydroxamic acid derivatives useful as antiinflammatory, antiasthma and antipsoriatic agents

Also Published As

Publication number Publication date
IT1228934B (it) 1991-07-10
GB2194531A (en) 1988-03-09
GB8717818D0 (en) 1987-09-03
FR2603284B1 (fr) 1990-11-16
CA1301179C (fr) 1992-05-19
JPS6360988A (ja) 1988-03-17
US4672075A (en) 1987-06-09
GB2194531B (en) 1990-07-18
DE3728350A1 (de) 1988-03-03
IT8721697A0 (it) 1987-08-24

Similar Documents

Publication Publication Date Title
ES512381A0 (es) "procedimiento de preparacion de disacaridos".
CS622779A2 (en) Zpusob vyroby 9 (hydroxyalkyl) hypoxanthinu
BE905109A (fr) Derives de distamycine et leur procede de fabrication.
ZA875059B (en) Solutions of oxazaphosphorins having improved stability and process for the preparation thereof
FR2603284A1 (fr) Derives d'acide 7-oxabicyclo(2.2.1.)heptane hydroxamique a action therapeutique
FR2506306A1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
FR2457278A1 (fr) Utilisation therapeutique de 9-aminoalkylfluorenes
ES548898A0 (es) Un procedimiento para la preparacion de derivados de 1,5-benzotiazepina'
ES481551A1 (es) Procedimiento de preparacion de nuevos compuestos bis (ari- loxicarboxilicos).
ES556551A0 (es) Un procedimiento para preparar un derivado de 1,5-benzotiazepina
FI890779A (fi) 14,17 -etano-14 -estratrieenejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä, ehkäisyaineina käytettäviä valmisteita
IE833006L (en) Substituted azabicycloalkanes.
FR2436134A1 (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
CA1257595A (fr) Derives de 5-halogenovinyl-2'-desoxyuridine
BE897883A (fr) Acide azetidinyl sulfonique et analogues a action therapeutique
FR2424912A1 (fr) Derives de l'imidazole utilisables notamment pour le traitement de l'hypertension
FR2425425A1 (fr) Derives d'acides benzoylphenoxyalcanoiques et leurs utilisations therapeutiques
SE8303569L (sv) Polyprenylforeningar
BE902911A (fr) Derives n-imidazolyliques et leur preparation
FR2603283A1 (fr) Analogues du 7-oxabicyclo(2.2.1.)heptane a action therapeutique
IL67324A0 (en) New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same
FR2452495A1 (fr) 2-epi-fortimicines a et b et leurs derives, utiles notamment comme antibiotiques, et intermediaires pour leur preparation
IL67323A0 (en) New dehydrocardenolide derivatives,process for the preparation thereof and pharmaceutical preparations containing the same
FR2456111A1 (fr) Nouveaux derives de l'indole, leur preparation et les medicaments qui les contiennent
KR840002374A (ko) 디옥산 진통제의 합성방법

Legal Events

Date Code Title Description
ST Notification of lapse